Ulcerative colitis

October 31, 2014October 31, 2014

FDA Endorses Further Studies on Ulcerative Colitis Drug from Lipid Therapeutics

News, Ulcerative colitis

Biopharmaceutical company Lipid Therapeutics has just announced the successful enrollment of the first batch of participants in a Phase III clinical trial for LT-02, the company’s first-in-class highly purified phosphatidylcholine pipeline product indicated for ... Read more

October 30, 2014October 30, 2014

Ulcerative Colitis Patients in UK Unsatisfied with Treatment

News, Ulcerative colitis

Most of the patients in the United Kingdom suffering from ulcerative colitis (UC) are not fully satisfied with the treatment their are receiving, and almost half of the patients regret they ... Read more

October 28, 2014September 28, 2016

MS Drug Candidate May Also Treat Ulcerative Colitis

News, Ulcerative colitis

Receptos, Inc., a San Diego-based biotechnology company, announced promising new clinical data for its drug candidate RPC1063 for ulcerative colitis. The drug was first discovered and synthesized at The Scripps Research Institute (TSRI) by ... Read more

October 24, 2014October 24, 2014

CORTIMENT Therapy for Ulcerative Colitis Receives Marketing Approval in Europe

News, Ulcerative colitis

Ferring Pharmaceuticals’ CORTIMENT (budesonide), a treatment for ulcerative colitis indicated for the induction of remission in patients who have an active, mild to moderate form of the disease, recently received marketing approval by the European ... Read more

October 17, 2014October 17, 2014

New Ulcerative Colitis Drug Study Results To Be Presented By Avaxia Biologics

News, Ulcerative colitis

New research and development news for ulcerative colitis (UC) indicates that a promising, new front-line therapy for the disease that can be taken in pill form may be making its ... Read more

October 15, 2014

New Research on Post-Colectomy Ulcerative Colitis Patients’ Quality of Life, Treatment Satisfaction

Ulcerative colitis

The conclusions of a new survey regarding quality of life for Ulcerative Colitis patients were recently released online and through social media channels as a means of improving care and ... Read more

October 10, 2014October 10, 2014

FDA Grants Salix’s UCERIS Rectal Foam for Ulcerative Colitis Final Approval

News, Ulcerative colitis

The U.S. Food and Drug Administration (FDA) recently approved UCERIS (budesonide) rectal foam, developed by Salix Pharmaceuticals, to induce remission in patients suffering from active mild-to-moderate distal ulcerative colitis (UC) extended up to ... Read more

October 7, 2014October 7, 2014

Whole-Foods Diet May Protect Against Leaky Gut and Multiple Sclerosis Progression

Crohn's Disease, IBD News, News, Ulcerative colitis

A decade ago, Shahram Lavasani, PhD, from Lund University in Sweden, was hard-pressed to find fellow scientists who agreed “leaky gut syndrome” could play a role in multiple sclerosis. “Back ... Read more

October 3, 2014October 3, 2014

Further Data Support Safety, Efficacy of Takeda’s Entyvio for UC, Crohn’s

Crohn's Disease, News, Ulcerative colitis

Takeda Pharmaceuticals, which is on the forefront of treating ulcerative colitis and Crohn’s disease with the newly launched Entyvio (vedolizumab), will present data concerning the open-label extension phase 3 study ... Read more

October 2, 2014October 2, 2014

Sigmoid Signs License Agreement with Pendopharm for UC Drug CyCol

News, Ulcerative colitis

Sigmoid Pharma Limited recently signed a licensing agreement with Pendopharm, a division of Pharmascience Inc., based in Montreal, Canada, for the exclusive rights to commercialize CyCol, an oral treatment for colon diseases like ulcerative ... Read more